Market Overview

UPDATE: Citigroup Downgrades Centene to Neutral on Limited Upside Potential

Share:
Related CNC
Earnings Scheduled For April 25, 2017
Deutsche Initiates Coverage On Health Stocks As National Health Insurance Debate Rages On
Zombie TrumpCare Is Back, But These Health Insurer Stocks Are Breaking Out (Investor's Business Daily)

Citigroup downgraded Centene (NYSE: CNC) from Buy to Neutral and maintained its $45 price target.

Citigroup noted, "After a 6% move on Tuesday, and with the stock up 75% from its June low, we're taking a step back on Centene. Even with $15 billion in revenue (that's a 50% increase relative to projected 2013 revenue of $10 billion), and a 1.5% net margin, Centene would earn around $4/share, which at a 12x multiple would value the company at $48, only modestly higher than the current price."

Centene closed at $44.99 on Tuesday.

Latest Ratings for CNC

DateFirmActionFromTo
Apr 2017Deutsche BankInitiates Coverage OnBuy
Jan 2017PiperJaffrayInitiates Coverage OnOverweight
Dec 2016JP MorganInitiates Coverage OnOverweight

View More Analyst Ratings for CNC
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Downgrades Analyst Ratings

 

Related Articles (CNC)

View Comments and Join the Discussion!